|
| 2003 | Pharmaceutical generics, vertical product differentiation and public policy
RePEc:upf:upfses:662 [Citation Analysis] | 5 |
| 2004 | Regional differences in socio-economic health inequalities in Spain
RePEc:upf:upfses:757 [Citation Analysis] | 4 |
| 2003 | Demand for pharmaceutical drugs: A choice modelling experiment
RePEc:upf:upfses:704 [Citation Analysis] | 4 |
| 2003 | A consistency test of the time trade-off
RePEc:upf:upfses:676 [Citation Analysis] | 4 |
| 2003 | Cost efficiency in primary care contracting: A stochastic frontier cost function approach
RePEc:upf:upfses:719 [Citation Analysis] | 4 |
| 2007 | Generic entry into a regulated pharmaceutical market
RePEc:upf:upfses:1014 [Citation Analysis] | 3 |
| 2001 | Demand for private health insurance: Is there a quality gap?
RePEc:upf:upfses:531 [Citation Analysis] | 3 |
| 2004 | Regulatory ambivalence and the limitations of pharmaceutical policy in Spain
RePEc:upf:upfses:762 [Citation Analysis] | 3 |
| 1997 | Unobserved heterogeneity and censoring in the demand for health care
RePEc:upf:upfses:240 [Citation Analysis] | 2 |
| 2004 | Are tax subsidies for private medical insurance self-financing? Evidence from a microsimulation model for outpatient and inpatient episodes
RePEc:upf:upfses:632 [Citation Analysis] | 2 |
| 2000 | Equity considerations in health care: An axiomatic bargaining approach
RePEc:upf:upfses:479 [Citation Analysis] | 2 |
| 2003 | Eliciting consumers preferences using stated preference discrete choice models: Contingent ranking versus choice experiment
RePEc:upf:upfses:705 [Citation Analysis] | 2 |
| 2002 | La imposición de los carburantes de automoción en España: algunas observaciones teóricas y empÃricas
RePEc:upf:upfses:609 [Citation Analysis] | 2 |
| 2001 | A multilevel analysis on the determinants of regional health care expenditure. A note
RePEc:upf:upfses:572 [Citation Analysis] | 2 |
| 2004 | Diversity and regional inequalities: Assessing the outcomes of the Spanish System of Health Care Services
RePEc:upf:upfses:745 [Citation Analysis] | 2 |
| 1998 | Las deducciones en el IRPF por gasto sanitario privado: situación actual y posibilidades de reforma
RePEc:upf:upfses:307 [Citation Analysis] | 2 |
| 2009 | Hybrid risk adjustment for pharmaceutical benefits
RePEc:upf:upfses:1139 [Citation Analysis] | 1 |
| 2004 | The effects of poor financial information systems on the long term sustainability of local public services. Empirical evidence from the Catalan Municipalities
RePEc:upf:upfses:746 [Citation Analysis] | 1 |
| 1999 | Review of the literature on reference pricing
RePEc:upf:upfses:362 [Citation Analysis] | 1 |
| 2004 | Responsabilidad social corporativa. Una visión desde la teorÃa económica
RePEc:upf:upfses:797 [Citation Analysis] | 1 |
| 1998 | Finance versus costs for teaching hospitals in Spain
RePEc:upf:upfses:265 [Citation Analysis] | 1 |
| 2003 | The impact of the reference price system on the pharmaceutical market: A theoretical approach
RePEc:upf:upfses:524 [Citation Analysis] | 1 |
| 2003 | Measurement and explanation of socioeconomic inequality in health with longitudinal data
RePEc:upf:upfses:711 [Citation Analysis] | 1 |
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.
